Inhaltsverzeichnis
Hepatic Transport Mechanisms, Intrahepatic Cholestasis and Gallstone Disease. - Liver Transplantation: State of the Art. - Mathematical Models for the Study of Liver Metabolism. - Mechanisms of Hepatic Fatty Acid Uptake. - Vesicular Transport of Fluid Phase Markers by Hepatocytes. - The Hepatic Uptake of Organic Anions: an Overview. - Mechanisms of Transport of Tauroconjugated Bile Acids in the Hepatocyte: Functional Significance. - Determinants of Biliary Cholesterol Secretion. - The Enterohepatic Circulation of Sulfated and Nonsulfated Bile Acids. - Esterogens and Bile Secretion. - Transport of UDPG in Vitro and Reversal of Ethanol-Induced Effects. - Associated Factors in Gallstone Disease. - Epidemiology of Gallstone Disease in Hungary. - The Role of the Gallbladder in Cholesterol Gallstone Pathogenesis. - Mechanism of Gallstone Formation in Obese Subjects. - Medical Treatment of Cholesterol Gallstones: Present and Future. - Bile Acid Treatment of Cholesterol Gallstones: A Reappraisal. - Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration. - Concluding Remarks. - Assessment of Liver Function. - Drug-Induced Liver Injury. - Biochemical Liver Tests: Recent Developments and Challenges. - Should Serum Bile Acid Determinations be performed Routinely in Patients with Liver Disease? . - Clinical Significance of Serum Bilirubins: Recent Advances. - Enzyme Pattern Changes in Preneoplastic and Neoplastic Lesions of the Liver. - The Value of Quantitation of Liver Function. - Quantitation of Liver Function: Antipyrine Metabolism, an Update. - Antipyrine Clearance: Evaluation of Simplified Methods in Chronic Liver Diseases. - Preoperative Care of Adult Patients Chosen for Liver Transplantation. - Assessment of Liver Function Before and After Liver Transplantation. - Hormones and Liver: Some Aspects of the Problem. - Effects of Thyroid Hormone Administration and of Thyroidectomy on the Metabolism of Bilirubin in Rats. - Comparison of Some Parameters of the Drug-Metabolizing Enzyme System and Liver Function Tests in Different Hepatic Diseases. - Interaction of Ethanol with Hepatic Drug Metabolism. - Antioxidant and Immunomodulant Effect of Hepatoprotective Drugs. - Stimulating Influence of a Flavonolignane Derivative on Proliferation, RNA Synthesis and Protein Synthesis in Liver Cells. - Renal Functional Impairment in Cirrhosis. - Pathophysiology of Cirrhotic Ascites. - Treatment of Ascites. - Low-Sodium Diet in the Management of Ascites in the Cirrhotic Patient. - Treatment of Refractory Ascites by Concentrated Ascitic Fluid Reinfusion. - Concluding Remarks. - Management of Liver Disease. - Liver and Aging. - Prognosis of Advanced Liver Disease. - Virus and Host Factors in the Evolution of Chronic Hepatitis Type B: Choice of Treatment. - Antiviral Treatment of Chronic Hepatitis. - Autoimmune Hepatitis: Diagnosis and Treatment. - Serum ? 2-microglobulin and Anti- ? 2m Antibodies in Chronic Liver Disease. - Treatment of Liver Cirrhosis. - Drug Therapy for Alcoholic Liver Disease. - Silymarin Treatment in Patients with Cirrhosis of the Liver A Prospective Study. - Protein Malnutrition in Chronic Liver Disease: Corrective Measures. - The Management of Primary Biliary Cirrhosis. - Impaired Calcitonin Response to Intravenous Calcium Load in Primary Biliary Cirrhosis. - Prevention of Upper Gastrointestinal Bleeding in Cirrhotic Patients. - Prophylactic Treatment of First Variceal Bleeding in Cirrhotics with Nadolol or Ranitidine: A Prospective Randomized Study. - Hemodynamic and Clinical Evaluation of Nadolol inthe Treatment of Portal Hypertension in Patients with Cirrhosis. - The GABA Hypothesis of the Pathogenesis of Hepatic Encephalopathy: Current Status. - Lactitol in the Prevention of Recurrent Hepatic Encephalopathy in Shunted Cirrhotic Patients. Preliminary Results of a Controlled Trial. - Concluding Remarks.